Tacrolimus versus cyclosporin A: A comparative study on rat renal allograft survival

Transplant International

Volumn 12, Issue 2, 1999, Pages 92-99

  Jiang, Hongsi ^a   Sakuma, Shozo ^b   Fujii, Yasutomo ^b   Akiyama, Yuka ^b   Ogawa, Toshikazu ^b   Tamura, Kouichi ^b   Kobayashi, Masakazu ^a   Fujitsu, Takashi ^b  

^a Fujisawa Res Institute of America   (United States)

^b ASTELLAS PHARMA INC   (Japan)

Author keywords

Cyclosporin A; Graft survival; Immunosuppression; Renal transplantation; Tacrolimus

Indexed keywords

CYCLOSPORIN A; INTERLEUKIN 2; TACROLIMUS;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL VACUOLE; COMPARATIVE STUDY; CONTROLLED STUDY; DOSE RESPONSE; GRAFT REJECTION; GRAFT SURVIVAL; HISTOLOGY; KIDNEY ALLOGRAFT REJECTION; KIDNEY FUNCTION; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; KIDNEY TUBULE; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SURVIVAL TIME;

ADMINISTRATION, ORAL; ANIMALS; CYCLOSPORINE; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; RATS; RATS, INBRED BN; RATS, INBRED LEW; TACROLIMUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0032945772     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001470050192     Document Type: Article

References (35)

1. Bismuth H for the European FK506 multicenter liver study group (1995) Comparison of FK506- and cyclosporine-based immunosuppression: FK506 therapy significantly reduces the incidence of acute, steroid-resistant, refractory, and chronic rejection whilst possessing a comparable safety profile. Transplant Proc 27: 45-49
2. Ciancio G, Roth D, Burke G, Nery J, Scantlebury V, Shapiro R, Esquenazi V, Olson L, Gharagozloo H, Miller J (1995) Renal transplantation in a new immunosuppressive era. Transplant Proc 27: 812-813
3. Fisher B, Lee S (1965) Microvascular surgical techniques in research, with special reference to renal transplantation in the rat. Surgery 58: 904-914
4. Gillis S, Smith KA (1977) Long-term culture of tumour-specific cytotoxic T cells. Nature 268: 154-156
5. Hart DN, Winearls CG, Fabre JW (1980) Graft adaptation: studies on possible mechanisms in long-term surviving rat renal allografts. Transplantation 30: 73-80
6. Hashimoto T, Zhong RZ, Garcia BM, Black RT, Behme RJ, Duff JH, Grant DR (1994) Treatment with FK506 prevents rejection of rat colon allografts. Transplantation 57: 1548-1554
7. Hutchinson IV (1980) Antigen-reactive cell opsonization (ARCO) and its role in antibody-mediated immune suppression. Immunol Rev 49: 167-197
8. Hutchinson IV, Zola H (1977) Antigen-reactive cell opsonization (ARCO): a mechanism of immunological enhancement. Transplantation 23: 464-469
9. Isai H, Painter DM, Sheil AG (1990) FK506 and orthotopic liver transplantation in the rat. Transplant Proc 22: 2125-2126
10. Japanese FK506 study group (1991) Japanese study of FK506 on kidney transplantation: results of an early phase II study. Transplant Proc 23: 3071-3074
11. Japanese FK506 study group (1991) Japanese study of FK506 on kidney transplantation: the benefit of monitoring the whole blood FK506 concentration. Transplant Proc 23: 3085-3088
12. Jiang H, Takahara S, Kyo M, Takano Y, Kokado Y, Ishibashi M, Okuyama A, Sonoda T (1992) In vivo and in vitro mechanisms of cardiac allograft acceptance in the rat after short treatment with 15-deoxyspergualin. Transpi Int 5: 139-144
13. Jiang H, Fujitsu T, Sakuma S, Fujii Y, Akiyama Y, Takahara S, Ishibashi M, Sonoda T, Shimomura K (1994) The effect of the immunologic marker RT2 on cardiac and renal allograft rejection in the rat. Transplantation 58: 1137-1139
14. Kino T, Hatanaka H, Hashimoto M, Nishiyama M, Goto T, Okuhara M, Kohsaka M, Aoki H, Imanaka H (1987) FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics. J Antibiot (Tokyo) 40: 1249-1255
15. Laskow DA, Vincenti F, Neylan J, Mendez R, Matas A (1995) Phase II FK506 multicenter concentration control study: one-year follow-up. Transplant Proc 27: 809-811
16. Lechler RI, Batchelor JR (1983) Mechanisms of reduced immunogenecity of retransplanted rat kidney allografts. Transplantation 15: 316-319
17. Liu J (1993) FK506 and cyclosporin, molecular probes for studying intracellular signal transduction. Immunol Today 14: 290-295
18. Liu J, Farmer JD Jr, Lane WS, Friedman J, Weissman I, Schreiber SL (1991) Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66: 807-815
19. Markus PM, Cai X, Ming W, Demetris AJ, Fung JJ, Starzl TE (1991) FK506 reverses acute graft-versus-host disease after allogeneic bone marrow transplantation in rats. Surgery 110: 357-363
20. Morris RE, Hoyt EG, Murphy MP, Shorthouse R (1989) Immunopharmacology of FK-506. Transplant Proc 21: 1042-1044
21. Murase N, Starzl TE, Tanabe M, Fujisaki S, Miyazawa H, Ye Q, Delaney CP, Fung JJ, Demetris AJ (1995) Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to Brown Norway rats. Transplantation 60: 158-171
22. Neuhaus P, Blumhardt G, Bechstein WO, Platz KP, Jonas S, Mueller AR, Langrehr JM, Lohmann R, Schattenfroh N, Knoop M, Keck H, Lemmens P, Raakow R, Lusebrink R, Slama KJ, Lobeck H, Hopf U (1995) Comparison of FK506 and cyclosporine-based immunosuppression in primary orthotopic liver transplantation - a single center experience. Transplantation 59: 31-40
23. Ochiai T, Nakajima K, Nagata M, Hori S, Asano T, Isono K (1987) Studies of the induction and maintenance of long-term graft acceptance by treatment with FK506 in heterotopic cardiac allotransplantation in rats. Transplantation 44: 734-738
24. Ochiai T, Nagata M, Nakajima K, Suzuki T, Sakamoto K, Enomoto K, Gunji Y, Uematsu T, Goto T, Hori S, Kenmochi T, Nakagori T, Asano T, Isono K, Hamaguchi K, Tsuchida H, Nakahara H, Inamura N, Gotoh T (1987) Studies of the effects of FK506 on renal allografting in the beagle dog. Transplantation 44: 729-733
25. Oluwole SF, Fawwaz RA, Reemtsma K, Hardy MA (1988) Induction of donor-specific unresponsiveness to rat cardiac allograft by donor leukocytes and cyclosporine. Transplantation 45: 1131-1135
26. Petersson E, Qi Z, Ekberg H, Ostraat O, Dohlsten M, Hedlund G (1997) Activation of alloreactive natural killer cells is resistant to cyclosporine. Transplantation 63: 1138-1144
27. Roelen DL, van Bree FP, Schanz U, van Rood JJ, Claas FH (1993) Differential inhibition of primed alloreactive CTLs in vitro by clinically used concentrations of cyclosporine and FK506. Transplantation 56: 190-195
28. Roy R, Lachance JG, Noel R, Grose JH, Beaudoin R (1986) Improved renal allograft function and survival following nonspecific blood transfusions. I. Induction of soluble suppressor factors inhibiting the mitogenic response. Transplantation 41: 640-643
29. Silvers WK, Kimura H, Desquenne-Clark L, Miyamoto M (1987) Some new perspectives on transplantation immunity and tolerance. Immunol Today 8: 117
30. Starzl TE, Todo S, Fung J, Demetris AJ, Venkataramman R, Jain A (1989) FK506 for liver, kidney, and pancreas transplantation. Lancet 2: 1000-1004
31. Starzl TE, Demetris AJ, Murase N, Thomson AW, Trucco M, Ricordi C (1993) Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantation. Immunol Today 14: 326-332
32. Thomson AW, Starzl TE (1993) New immunosuppressive drugs: mechanistic insights and potential therapeutic advances. Immunol Rev 136: 71-98
33. Todo S, Demetris A, Ueda Y, Imventarza O, Cadoff E, Zeevi A, Starzl TE (1989) Renal transplantation in baboons under FK506. Surgery 106: 444-450
34. Todo S, Fung JJ, Starzl TE, Tzakis A, Demetris AJ, Kormos R, Jain A, Alessiani M, Takaya S, Shapiro R (1990) Liver, kidney, and thoracic organ transplantation under FK506. Ann Surg 212: 295-305
35. U.S. FK506 Multicenter (1994) A comparison of tacrolimus (FK506) and Cyclosporine for immunosuppression in liver transplantation. N Engl J Med 331: 1110-1115